Overactive bladder treating drug
A therapeutic agent for overactive bladder containing tamsulosin or a pharmaceutically acceptable salt thereof as an effective ingredient.
1 . A pharmaceutical composition for the therapy of overactive bladder where said composition contains tamsulosin or a pharmaceutically acceptable salt thereof as an effective ingredient.
2 . A pharmaceutical composition for the therapy of overactive bladder according to claim 1 in which said composition contains tamsulosin hydrochloride.
3 . A pharmaceutical composition for the therapy of overactive bladder according to claim 1 or claim 2 in which said composition contains muscarinic receptor antagonist.
4 . A pharmaceutical composition for the therapy of overactive bladder according to claim 3 in which said composition contains qunuclidin-3′-yl 1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate or its salt as an effective ingredient.
5 . The use of tamsulosin or a pharmaceutically acceptable salt thereof for the manufacture of a therapeutic agent for overactive bladder.
6 . The use of tamsulosin or a pharmaceutically acceptable salt thereof for the manufacture of a medicament to be used in combination with muscarinic receptor antagonist in the treatment of overactive bladder.
7 . A method for the therapy of overactive bladder where said method includes administration of therapeutically effective amount of tamsulosin or a pharmaceutically acceptable salt thereof to a patient.
8 . A method for the therapy of overactive bladder where said method includes administration of therapeutically effective amount of tasulosin or a pharmaceutically acceptable salt thereof to a patient in combination with therapeutically effective amount of muscarinic receptor antagonist.